NEUROFILAMENT INVOLVEMENT IN LEWY BODY DISORDERS
NEUROFILAMENT INVOLVEMENT IN LEWY BODY DISORDERS
批准号:
2271298
负责人:
WILLIAM D HILL
金额:
$8.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-05-01 至 1999-04-30
关键词:
Alzheimer's disease Chordata Parkinson's disease RNase protection assay antibody cellular pathology epitope mapping in situ hybridization inclusion body monoclonal antibody nervous system disorder neurofilament neurofilament proteins phosphorylation posttranslational modifications protein biosynthesis protein isoforms protein purification proteolysis
中文摘要
路易体是出现在特定脑干中的丝状包涵体,
边缘系统和新皮层神经元在几个残疾和痴呆
神经退行性疾病,包括帕金森氏病、弥漫性路易氏病
身体疾病和阿尔茨海默病的一个子集。致病的
导致路易体形成的事件,也不是路易体的组成
是已知的。
这项研究的长期目标是确定关键
路易体的组成部分,以表征直接致病性
导致路易体形成的事件以及更早或更早的事件
主要病理事件,并澄清之间的关系
阿尔茨海默病和路易体相关疾病。本提案中
将追求一套有限的目标,重点是
神经丝三联体蛋白在路易体丝形成中的作用,
在这些疾病的发病机制中作为靶点的作用。
神经丝蛋白是应用的焦点,因为它们是
目前最有说服力和一致的潜在路易体
细丝分子
本申请的总体假设是神经丝
路易体相关疾病(例如
帕金森病、弥漫性路易体病和阿尔茨海默病的亚类
疾病具体的目标集中在神经丝参与这些
路易体相关疾病。这些目标包括分析
脆弱神经元群体中的神经丝代谢水平
mRNA和蛋白质表达,包括翻译后修饰,
神经丝亚单位为了完成该表位作图,
与结合共聚焦显微镜的独特抗体库一起使用,
显微镜、定量原位杂交和核糖核酸酶保护
测定。具体目标还包括隔离和
路易体的表征,以直接确定是否
神经丝亚单位是组成部分,
修改.新的策略将用于分离路易体
(基于亲和力)和路易体特异性抗体的产生
(基于容忍度)。此外,这些信息将被比较
皮质和皮质下神经元群体之间以及
疾病类别。
虽然神经丝强烈地参与了
路易体细丝,以及神经丝加工的改变,
怀疑路易体相关疾病,他们的问题,
参与尚未解决。这项建议的目的是
朝着更清楚地评估神经丝在这些过程中的作用迈进,
紊乱
英文摘要
Lewy bodies are filamentous inclusions that occur in selected brainstem,
limbic, and neocortical neurons in several disabling and dementing
neurodegenerative diseases, including Parkinson's disease, diffuse Lewy
body disease, and a subset of Alzheimer's disease. Neither the pathogenic
events leading to Lewy body formation, nor the composition of Lewy bodies
are known.
The long-term objectives of this research are to identify the key
components of Lewy bodies, to characterize both immediate pathogenic
events leading to the formation of Lewy bodies as well as earlier or more
primary pathological events and to clarify the relationship between
Alzheimer's disease and Lewy body associated disorders. In this proposal
a limited set of goals will be pursued that focus on the role of the
neurofilament triplet proteins in the formation of Lewy body filaments and
on their role as a target in the pathogenesis of these disorders.
Neurofilament proteins are the focus of the application because they are
currently the most convincing and consistent of the potential Lewy body
filament molecules.
The overall hypothesis of this application is that neurofilament
metabolism is disrupted in Lewy body associated disorders such as
Parkinson's disease, diffuse Lewy body disease, and subsets of Alzheimer's
disease. The specific aims center on neurofilament involvement in these
Lewy body associated diseases. These aims incorporate analysis of
neurofilament metabolism in vulnerable neuron populations at the level of
mRNA and protein expression, including post-translational modifications to
neurofilament subunits. To accomplish this epitope mapping will be
employed with a unique library of antibodies combined with confocal
microscopy, quantitative in situ hybridization and ribonuclease protection
assays. The specific aims also incorporate the isolation and
characterization of Lewy bodies in order to directly determine if
neurofilament subunits are components and if they are post-translationally
modified. Novel strategies will be used for the isolation of Lewy bodies
(affinity based) and the production of Lewy body specific antibodies
(tolerization based). Additionally, this information will be compared
between cortical and subcortical neuronal populations as well as across
disease categories.
While neurofilaments have been strongly implicated in the formation of
Lewy body filaments, and alterations in neurofilament processing are
suspected in Lewy body associated disorders, the question of their
involvement has not been settled. The intention of this proposal is to
move towards a clearer assessment of the role of neurofilaments in these
disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Age-Related Kynurenine Accumulation Impairs miRNA and Hdac Epigenetic Regulation of the SDF-1 Axis Resulting in Bone Loss
-
批准号:9973283
-
项目类别:
-
资助金额:$52.39万
-
财政年份:2020
-
负责人:WILLIAM D HILL
-
依托单位:
Age-Related Kynurenine Accumulation Impairs miRNA and Hdac Epigenetic Regulation of the SDF-1 Axis Resulting in Bone Loss
-
批准号:10375583
-
项目类别:
-
资助金额:$49.27万
-
财政年份:2020
-
负责人:WILLIAM D HILL
-
依托单位:
Kynurenine Pathway Regulation of CNS Senescence in Alzheimer's Disease Pathology
-
批准号:10713140
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2020
-
负责人:WILLIAM D HILL
-
依托单位:
Age-Related Kynurenine Accumulation Impairs miRNA and Hdac Epigenetic Regulation of the SDF-1 Axis Resulting in Bone Loss
-
批准号:10216949
-
项目类别:
-
资助金额:$50.12万
-
财政年份:2020
-
负责人:WILLIAM D HILL
-
依托单位:
Age-Related Kynurenine Accumulation Impairs miRNA and Hdac Epigenetic Regulation of the SDF-1 Axis Resulting in Bone Loss
-
批准号:10609892
-
项目类别:
-
资助金额:$49.16万
-
财政年份:2020
-
负责人:WILLIAM D HILL
-
依托单位:
Bad to the Bone: Age-related Increases in Serum SDF-1 Leads to Bone Loss with Age
-
批准号:8810590
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:WILLIAM D HILL
-
依托单位:
Bad to the Bone: Age-related Increases in Serum SDF-1 Leads to Bone Loss with Age
-
批准号:8967197
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:WILLIAM D HILL
-
依托单位:
NEUROFILAMENT INVOLVEMENT IN LEWY BODY DISORDERS
-
批准号:2271299
-
项目类别:
-
资助金额:$9.32万
-
财政年份:1994
-
负责人:WILLIAM D HILL
-
依托单位:
NEUROFILAMENT INVOLVEMENT IN LEWY BODY DISORDERS
-
批准号:2416348
-
项目类别:
-
资助金额:$9.7万
-
财政年份:1994
-
负责人:WILLIAM D HILL
-
依托单位:
NEUROFILAMENT INVOLVEMENT IN LEWY BODY DISORDERS
-
批准号:2271297
-
项目类别:
-
资助金额:$8.93万
-
财政年份:1994
-
负责人:WILLIAM D HILL
-
依托单位:
NEUROFILAMENT INVOLVEMENT IN LEWY BODY DISORDERS
-
批准号:2703032
-
项目类别:
-
资助金额:$10.08万
-
财政年份:1994
-
负责人:WILLIAM D HILL
-
依托单位:
EPITOPE ANALYSIS OF NEUROFIBRILLARY TANGLE PROTEINS
-
批准号:3028697
-
项目类别:
-
资助金额:$2.86万
-
财政年份:1990
-
负责人:WILLIAM D HILL
-
依托单位:
EPITOPE ANALYSIS OF NEUROFIBRILLARY TANGLE PROTEINS
-
批准号:3028696
-
项目类别:
-
资助金额:$2.1万
-
财政年份:1989
-
负责人:WILLIAM D HILL
-
依托单位:
EPITOPE ANALYSIS OF NEUROFIBRILLARY TANGLE PROTEINS
-
批准号:3028695
-
项目类别:
-
资助金额:$1.9万
-
财政年份:1989
-
负责人:WILLIAM D HILL
-
依托单位:
NUTRIENT MEDIATED AGE-RELATED CHANGES IN SDF-1 RESULTS IN BONE LOSS
-
批准号:8093269
-
项目类别:
-
资助金额:$26.76万
-
财政年份:--
-
负责人:WILLIAM D HILL
-
依托单位:
海外基金